These researchers reported that the regional intraventricular delivery of HER2-redirected CAR-Ts resulted in promising therapeutic responses against leptomeningeal disease and brain-metastasized breast cancer in human xenograft mouse models (106). This evidence concerns the gene ERBB2 and breast carcinoma.